1262414-14-1

Basic information

• Product Name: 4-[(2S)-3-(3-ethyl-5-methyl-4-oxiranylmethoxy-phenyl)-[1,2,4]oxadiazol-5-yl]-2-(1-ethyl-propyl)-6-methoxy-pyridine
• Synonyms: 4-[(2S)-3-(3-ethyl-5-methyl-4-oxiranylmethoxy-phenyl)-[1,2,4]oxadiazol-5-yl]-2-(1-ethyl-propyl)-6-methoxy-pyridine
• CAS NO: 1262414-14-1
• Molecular Weight: 437.539
• Mol File: 1262414-14-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4-[(2S)-3-(3-ethyl-5-methyl-4-oxiranylmethoxy-phenyl)-[1,2,4]oxadiazol-5-yl]-2-(1-ethyl-propyl)-6-methoxy-pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 4-[(2S)-3-(3-ethyl-5-methyl-4-oxiranylmethoxy-phenyl)-[1,2,4]oxadiazol-5-yl]-2-(1-ethyl-propyl)-6-methoxy-pyridine(1262414-14-1)
• EPA Substance Registry System: 4-[(2S)-3-(3-ethyl-5-methyl-4-oxiranylmethoxy-phenyl)-[1,2,4]oxadiazol-5-yl]-2-(1-ethyl-propyl)-6-methoxy-pyridine(1262414-14-1)

Safety Data

• Hazardous Substances Data: 1262414-14-1(Hazardous Substances Data)

Upstream product

• 67843-74-7 (S)-epichlorohydrin 
• 1262414-13-0 2-ethyl-4-{5-[2-(1-ethyl-propyl)-6-methoxy-pyridin-4-yl]-[1,2,4]oxadiazol-3-yl}-6-methyl-phenol 
• 15855-06-8 2-chloro-6-methoxy-isonicotinic acid 
• 51594-55-9 (R)-(-)-epichlorohydrin 
• 42521-10-8 2-chloro-6-methoxyisonicotinic acid methyl ester 
• 1122089-63-7 2-methoxy-6-(pentan-3-yl)isonicotinic acid 
• 1122089-65-9 methyl 2-methoxy-6-(pentan-3-yl)-isonicotinate 
• 5398-44-7 2,6-dichloropyridine-4-carboxylic acid 

Downstream Products

• 1262414-15-2 (2S)-1-(2-ethyl-4-{5-[2-(1-ethyl-propyl)-6-methoxy-pyridin-4-yl]-[1,2,4]oxadiazol-3-yl}-6-methyl-phenoxy)-3-methylamino-propan-2-ol 
• 1262414-12-9 N-[(2S)-3-(2-ethyl-4-{5-[2-(1-ethyl-propyl)-6-methoxy-pyridin-4-yl]-[1,2,4]oxadiazol-3-yl}-6-methyl-phenoxy)-2-hydroxy-propyl]-2-hydroxy-N-methyl-acetamide 

Relevant articles and documents

PYRIDIN-4-YL DERIVATIVES

The invention relates to pyridine derivatives of Formula (I), wherein A, R1, R2, R3, and R4 are as described in the description, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents.